MedTrace Logo

Whole-life Investigation of Lishui Longevity

NCT07592962 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2026-05-18

No results posted yet for this study

Summary

1. To establish a standardized, normalized and scientific joint screening and follow-up management system for chronic disease multimorbidity in Lishui City, and early identify common risk factors of major chronic diseases such as cardiovascular and cerebrovascular diseases and tumors.
2. To carry out targeted intervention and long-term follow-up for high-risk populations, reduce the incidence risk of major chronic diseases in the target population, improve residents' health status and grassroots comprehensive prevention and treatment capacity of chronic diseases, and provide scientific evidence and practical support for the construction of Healthy Lishui.

Conditions

Sponsors & Collaborators

  • The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital

    lead OTHER

Principal Investigators

  • Jiansong Ji, PhD · The Central Hospital of Lishui City

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-18
Primary Completion
2036-05-31
Completion
2036-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07592962 on ClinicalTrials.gov